The Netherlands also slows down on "trans children"
The 2006 study on which the so-called "Dutch Protocol" exported throughout the world is based - the administration of puberty blockers to minors with behavior that does not conform to their birth sex - was financed by the pharmaceutical company that produces the blockers, and is been discredited several times. As in the UK, Sweden, Finland, even in that country today there is a call for a stop to these "therapies" which cause serious damage to health

Share this article

Is called “Dutch Protocol” The treatment of children with gender dysphoria with puberty blockers. And it is based on a single study from 2006 which introduces the concept of “sex change for transgender children” and that would have been funded by Ferring Pharmaceuticals, the company that markets triptorelin, the drug with which the natural development of girls and boys is stopped. This is revealed by a reportage by journalist Jan Kuitenbrouwer and sociologist Peter Vasterman recently published on NRC Handelsblad, one of the largest Dutch newspapers.

There Triptorelin is a drug used primarily in the treatment of hormone-sensitive tumors, such as prostate cancer and breast cancer, in the treatment of precocious puberty, endometriosis, uterine fibroids and in assisted reproduction. Use as a puberty blocker is off-label, but it was authorized in many countries also under pressure from transactivism. AIFA has authorized it in Italy for some years.

The authors of the report report that “the scientific foundations of the Dutch protocol turn out to be rather shaky”. As stated in the article, the study has been repeatedly discredited due to the lack of a control group, the short follow-up period, the number of participants who were lost to follow-up, and other key methodological flaws. Furthermore, one of the participants in this historic study even died due to complications from the so-called "gender confirmation" surgery, as it is called in the jargon of transactivists.

But all this did not prevent the puberty suppression protocol from being blindly adopted in the international world of "gender medicine" without thinking about the obvious health risks resulting from arrested development in girls and boys.

It has long been observed that almost all children who are given puberty blockers go on to take hormones of the opposite sex and often even undergo genital and breast surgery. Puberty blockers would therefore not be a “pause button” to give time to teenager dysphoric to decide their gender, as their promoters claim, but they would be instead “a self-fulfilling prophecy”, write Kuitenbrouwer and Vasterman.

Added to this is the growing list of side effects of these drugs, from impaired bone formation to infertility and loss of sexual function. Recently the Food and Drug Administration United States has added the obligation to write on the label the warning that puberty blockers can cause brain edema.

The report also records the changes in the phenomenon as of the study's publication date: in 2006, the number of children suffering from gender dysphoria and seeking medical treatment was negligible, and almost all were boys. Subsequently, a sharp increase in cases and the number of girls with gender dysphoria has grown to far exceed that of boys: Adolescent girls now make up the majority of cases treated in gender clinics, in the Netherlands as in other countries. The turning point can be identified around 2013, coinciding with the greater diffusion of smartphones and social media and the increase in popularity of the “trans rights” movement.

Kuitenbrouwer and Vasterman wonder why this phenomenon would only concern adolescent girls, the demographic group notoriously most susceptible to social contagions, and they also hope for independent investigations in the Netherlands like those conducted in Sweden, Finland and England which led the governments of these countries to abandon the "affirmative" model to return to a psychotherapeutic approach to the treatment of these vulnerable young people.

Here the text of the Dutch report.

Here the news in English.

Translation by Maria Celeste

Share this article
Scroll to Top